Effect of cimetidine and probenecid on pilsicainide renal clearance in humans

Clinical Pharmacology and Therapeutics

Volumn 67, Issue 3, 2000, Pages 222-228

  Shiga, Tsuyoshi ^a,b   Hashiguchi, Masayuki ^a,b,c   Urae, Akinori ^a,b   Kasanuki, Hiroshi ^a,b   Rikihisa, Tadaaki ^a,b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Kyushu Clinical Pharmacology Research Clinic   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; PILSICAINIDE; PROBENECID; SUNRYTHM; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DETERMINATION; DRUG HALF LIFE; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; KIDNEY CLEARANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034025366     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1067/mcp.2000.104018     Document Type: Article

References (30)

1. 1. Campbell TJ. Kinetics of onset of class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification. Cardiovasc Res 1983; 17: 334-52.
2. 2. Hattori Y, Hidaka T, Aisaka K, Satoh F, Ishihara T. Effects of SUN 1165, a new antiarrhythmic agents, on the kinetics of rate-dependent block of Na channels and ventricular conduction of extrasystoles. J Cardiovasc Pharmacol 1988;11:407-12.
3. 3. Aisaka K, Hidaka T, Inomata N, Hamasaki S, Ishihara T, Morita M. N-(2,6-Dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate (SUN 1165), a new potent and long-acting antiarrhythmic agent. Arzneimitelforschung 1985;32:1239-45.
4. 4. Hashimoto K, Ishii M, Komori S, Mitsuhashi H. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs, propafenone, tocainide, and SUN 1165. Heart Vessels 1985;1:29-35.
5. 5. Niitani H, Kato K, Sugimoto T, Katagiri T, Hayakawa H, Hiejima K, et al. Clinical evaluation of SUN 1165, a new antiarrhythmic agent, in patients with arrhythmias: multicenter cooperative study of early phase II trial [in Japanese]. J Clin Ther Med 1989;5:943-59.
6. 6. Hayashi T, Kanai Y, Takeuchi Y, Takehisa M, Sugita O, Ohnuma N. Studies on metabolism and disposition of a new antiarrhythmic agent, SUN1165 (I)-absorption and excretion of SUN1165 in rats [in Japanese]. Clin Rep 1989;23:17-29.
7. 7. Takabatake E, Isobe M, Natsuki R, Sone T, Matsuo R. Studies on metabolism and disposition of a new antiarrhythmic agent, SUN1165 (V)-metabolism and disposition of SUN1165 in dogs [in Japanese]. Clin Rep 1989;23:85-97.
8. 8. Hayashi T, Takehisa M, Sugita O, Oonuma N. Studies on metabolism and disposition of a new antiarrhythmic agent, SUN1165 (VI)-metabolism and disposition of SUN1165 in monkey [in Japanese]. Clin Rep 1989;23:99-105.
9. 9. Nakashima M, Kanamaru M, Uematsu T, Ohnuma N, Hayashi T, et al. Phase I study of SUN 1165, a novel antiarrhythmic agent No. 1: single dose study [in Japanese]. J Clin Ther Med 1989;5:661-78.
10. 10. Takabatake T, Ohta H, Yamamoto Y, Ishida Y, Hara H, Shioki Y, et al. Pharmacokinetics of SUN 1165, a new antiarrhythmic agent, in patients with renal dysfunction [in Japanese]. Jpn Pharmacol Ther 1989;17:215-25.
11. 11. Oda S, Tsukazaki T, Kuroo M, Kuramoto K. Pharmacokinetics and pharmacodynamics of SUN 1165 in geriatric patients [in Japanese]. Geriat Med 1989;27:1033-41.
12. 12. Moller JV, Sheikh I. Renal organic anion transport system: Pharmacological, physiological, and biochemical aspects. Pharmacol Rev 1983;34:315-58.
13. 13. Rennick BR. Renal tubule transport of organic cations. Am J Physiol 1981;240:F83-9.
14. 14. Mckinney TD, Myers P, Speeg Jr. Cimetidine secretion by rabbit renal tubules in vitro. Am J Physiol 1981;241: F69-76.
15. 15. Cacini W, Keller MB, Grund VR. Accumulation of cimetidine by kidney cortex slices. J Pharmacol Exp Ther 1982;221:342-6.
16. 16. Gisclon L, Wong FM, Giacomini KM. Cimetidine transport in isolated luminal membrane vesicles from rabbit kidney. Am J Physiol 1987;253(1 Pt 2):F141-50.
17. 17. McKinney TD, Kunnemann ME. Cimetidine transport in rabbit renal cortical brush-border membrane vesicles. Am J Physiol 1987;252:F525-35.
18. 18. Hsyu PH, Gisclon LG, Hui AC, Giacomini KM. Interactions of organic anions with the organic cation transporter in renal BBMV. Am J Physiol 1988; 254:F56-61.
19. 19. Lin JH, Los LE, Ulm EH, Duggan DE. Kinetic studies on the competition between famotidine and cimetidine in rats: evidence of multiple renal secretory systems for organic cations. Drug Metab Dispos 1988;16:52-6.
20. 20. Gisclon LG, Boyd RA, Williams RL, Giacomini KM. The effect of probenecid on the renal elimination of cimetidine. Clin Pharmacol Ther 1989;45:444-52.
21. 21. Inotsume N, Nishimura M, Nakano M, Fujiyama S, Sato T. The inhibitory effect of probenecid on renal excretion of famotidine in young, healthy volunteers. J Clin Pharmacol 1990;30:50-6.
22. 22. Somogyi A, McLean A, Heinzow B. Cimetidine-procainamide pharmacokinetic interaction in man: evidence of competition for tubular secretion of basic drugs. Eur J Clin Pharmacol 1983;25:339-45.
23. 23. Christian CD Jr, Meredith CG, Speeg KV Jr. Cimetidine inhibits renal procainamide clearance. Clin Pharmacol Ther 1984;36:221-7.
24. 24. van Crugten J, Bochner F, Keal J, Somogyi A. Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans: studies with anionic, cationic and zwitterionic drugs. J Pharmacol Exp Ther 1986;236:481-7.
25. 25. Muirhead MR, Somogyi A, Rolan PE, Bochner F. Effect of cimetidine on renal and hepatic drug elimination: studies with triamterene. Clin Pharmacol Ther 1986; 40:400-7.
26. 26. Somogyi A, Stockley C, Keal J, Rolan P, Bochner F. Reduction of metformin renal tubular secretion by cimetidine in man. Br J Clin Pharmacol 1987;23:545-51.
27. 27. Cunningham RF, Israili ZH, Dayton PG. Clinical pharmacokinetics of probenecid. Clin Pharmacokinet 1981;6: 135-51.
28. 28. Kinsella JL, Holohan PD, Pessah NI, Ross CR. Transport of organic ions in renal cortical luminal and antiluminal membrane vesicles. J Pharmacol Exp Ther 1979; 209:443-50.
29. 29. Takano M, Inui KI, Okano T, Hori R. Cimetidine transport in rat renal brush border and basolateral membrane vesicles. Life Sci 1985;37:1579-85.
30. 30. Rennick B, Ziemniak J, Smith I, Taylor M, Acara M. Tubular transport and metabolism of cimetidine in chicken kidneys. J Pharmacol Exp Ther 1984;228: 387-92.